2XE1
Molecular insights into clinically isolated OmpC mutants and their role in multi-drug resistance
Replaces: 2IXXExperimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID14-1 |
Synchrotron site | ESRF |
Beamline | ID14-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | ADSC CCD |
Spacegroup name | P 63 2 2 |
Unit cell lengths | 120.400, 120.400, 158.100 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 47.030 - 2.500 |
R-factor | 0.19414 |
Rwork | 0.193 |
R-free | 0.21812 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1osm |
RMSD bond length | 0.005 |
RMSD bond angle | 0.881 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | MOLREP |
Refinement software | REFMAC (5.6.0060) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 47.000 | 2.500 |
High resolution limit [Å] | 2.500 | 2.500 |
Rmerge | 0.100 | 0.520 |
Number of reflections | 22833 | |
<I/σ(I)> | 14 | 3.4 |
Completeness [%] | 99.5 | 99.5 |
Redundancy | 9 | 9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 |